3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
13
Oropharyngeal Neoplasms
11
Lung Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Mouth Neoplasms
8
Laryngeal Neoplasms
8
Carcinoma
8
Urinary Bladder Neoplasms
6
Nasopharyngeal Carcinoma
6
Hypopharyngeal Neoplasms
6
Pancreatic Neoplasms
5
Mesothelioma, Malignant
5
Uterine Cervical Neoplasms
4
Ovarian Neoplasms
4
Medulloblastoma
4
Ganglioneuroblastoma
4
Gallbladder Neoplasms
4
Neuroblastoma
3
Lymphoid Interstitial Pneumonia
3
Cholangiocarcinoma
3
Triple Negative Breast Neoplasms
2
Salivary Gland Neoplasms
2
Paranasal Sinus Neoplasms
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Transitional Cell
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Interventions
Specimen Handling
3
olaparib
2
durvalumab
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Ipilimumab
2
CTLA-4 Antigen
2
serabelisib
1
sapanisertib
1
defactinib
1
ceralasertib
1
cediranib
1
capivasertib
1
cabozantinib
1
Restraint, Physical
1
RO5126766
1
Paclitaxel
1
Immunoglobulin G
1
Hysterectomy
1
Fluid Therapy
1
Disulfides
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Endometrioid
×
1,2-diaminocyclohexaneplatinum II citrate
×
1 year
×
Clear all
No trials found.